Japan Video Games Market Report 2023- In-Depth Analysis of Japan’s Robust Gaming Market Unveiled – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Japan Games Market Report" report from Niko Partners, Inc. has been added to…
2 years ago
Alex
2024 to Bring “Reputational Security†into Focus – Crisis Management Centre
KUALA LUMPUR, Malaysia--(BUSINESS WIRE)--#CrisisCommunication--The Crisis Management Centre foresees that 2024 will carry with it increased…
2 years ago
FDA Approves Label Update for BRUKINSA® (zanubrutinib) in Chronic Lymphocytic Leukemia (CLL)
U.S. label update includes superior progression-free survival results from the Phase 3 ALPINE head-to-head trial…
2 years ago
VOOPOO DRAG X2 and DRAG S2 with PnP X Platform have Arrived in the MENA
SHENZHEN, China--(BUSINESS WIRE)--VOOPOO is excited to announce the arrival of the VOOPOO DRAG X2, DRAG…
2 years ago
Cellusion Receives U.S. FDA Orphan Drug Designation for CLS001
TOKYO--(BUSINESS WIRE)--Cellusion Inc. (CEO: Shin Hatou, M.D. Ph.D., “Cellusionâ€), a deep tech start-up developing a…
2 years ago
BANDAI: “UNION ARENA English version†Announcement Program
Get the latest information and hear the comments from voice actors! The release in North…
2 years ago
Elliptic Labs Deployed on HONOR 90 GT Smartphone
OSLO, Norway--(BUSINESS WIRE)--#AIVirtualProximitySensor--Elliptic Labs (OSE: ELABS), a global AI software company and the world leader…
2 years ago
FPT Hits One Billion USD Revenue in Global IT Services for the First Time
HANOI, Vietnam--(BUSINESS WIRE)--#AI--Global technology corporation FPT has surpassed one billion USD in the global IT…
2 years ago
Rare Element Resources Receives DOE Approval to Proceed with Construction of Rare Earth Processing and Separation Demonstration Plant
Plant Operations Expected to Commence in 2024 LITTLETON, Colo.--(BUSINESS WIRE)--Rare Element Resources Ltd. (the “Company 
2 years ago
Takeda Announces China NMPA Approval of LIVTENCITY® (maribavir) for the Treatment of Adults With Post-transplant Cytomegalovirus (CMV) Refractory to Prior Therapies
- LIVTENCITY Is the First and Only Inhibitor of CMV-specific UL97 Protein Kinase Approved in…
2 years ago